CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 83 filers reported holding CYTOSORBENTS CORP in Q1 2020. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,130,000 | +136.4% | 114,109 | +84.7% | 0.51% | +81.4% |
| Q1 2020 | $478,000 | -24.1% | 61,795 | -20.8% | 0.28% | -18.8% |
| Q4 2018 | $630,000 | -51.4% | 78,027 | -22.3% | 0.34% | -34.3% |
| Q3 2018 | $1,296,000 | -5.1% | 100,440 | -16.2% | 0.52% | -21.3% |
| Q2 2018 | $1,366,000 | – | 119,806 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 450,000 | $846,000 | 0.90% |
| Skylands Capital, LLC | 2,944,670 | $5,535,980 | 0.84% |
| Sargent Investment Group, LLC | 1,257,048 | $2,363,250 | 0.57% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 197,940 | $372,127 | 0.52% |
| Avenir Corp | 2,717,397 | $5,108,706 | 0.48% |
| Granahan Investment Management | 1,552,393 | $2,918,499 | 0.10% |
| Seelaus Asset Management LLC | 20,450 | $38,446 | 0.04% |
| HighMark Wealth Management LLC | 10,000 | $18,800 | 0.02% |
| Key Client Fiduciary Advisors, LLC | 13,000 | $24,440 | 0.02% |
| Eudaimonia Partners, LLC | 23,500 | $44,180 | 0.01% |